Literature DB >> 8986719

Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways.

S A Oakes1, F Candotti, J A Johnston, Y Q Chen, J J Ryan, N Taylor, X Liu, L Hennighausen, L D Notarangelo, W E Paul, R M Blaese, J J O'Shea.   

Abstract

Both IL-2 and IL-4 bind to receptors containing the common gamma chain and JAK3. Although JAK3 is required for proper lymphoid development, the precise roles of this kinase in IL-2 and IL-4 signaling in lymphocytes have not been defined. Here, we have studied IL-2 and IL-4 signaling in B cell lines lacking JAK3. Although IL-2-induced phosphorylation of IL-2R beta, JAK1, and STAT5 all required the presence of JAK3, IL-4-mediated phosphorylation of JAK1, STAT6, and insulin receptor substrates 1 and 2 did not. However, IL-4-induced effects were clearly improved following JAK3 expression. These data indicate that IL-4 signaling occurs in the absence of of JAK3, but is comparatively inefficient. These findings may help in understanding the pathogenesis of the immunodeficiency that occurs with mutations of JAK3 and may suggest a mechanism for the pleiotropic effects of IL-4.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8986719     DOI: 10.1016/s1074-7613(00)80274-5

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  33 in total

1.  IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB.

Authors:  Y Abu-Amer
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

2.  Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: activation of syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation.

Authors:  Y J Zhou; K S Magnuson; T P Cheng; M Gadina; D M Frucht; J Galon; F Candotti; R L Geahlen; P S Changelian; J J O'Shea
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

Review 3.  Gene therapy of primary immunodeficiencies.

Authors:  F Candotti; R M Blaese
Journal:  Springer Semin Immunopathol       Date:  1998

Review 4.  Severe combined immune deficiencies due to defects of the common gamma chain-JAK3 signaling pathway.

Authors:  F Candotti; J J O'Shea; A Villa
Journal:  Springer Semin Immunopathol       Date:  1998

Review 5.  Advances in the understanding of cytokine signal transduction: the role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency.

Authors:  J J O'Shea; L D Notarangelo; J A Johnston; F Candotti
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

6.  An alternatively spliced IL-15 isoform modulates abrasion-induced keratinocyte activation.

Authors:  Tsung-Lin Lee; Mei-Ling Chang; Yu-Jei Lin; Ming-Hsun Tsai; Yi-Hsuan Chang; Che-Ming Chuang; Yun Chien; Tomasz Sosinowski; Chih-Hsiu Wang; Yi-Yuan Chen; Chien-Kuo Lee; Jau-Shiuh Chen; Li-Fang Wang; John T Kung; Chia-Chi Ku
Journal:  J Invest Dermatol       Date:  2015-01-23       Impact factor: 8.551

7.  The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals.

Authors:  M Chen; A Cheng; Y Q Chen; A Hymel; E P Hanson; L Kimmel; Y Minami; T Taniguchi; P S Changelian; J J O'Shea
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

8.  IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivo.

Authors:  Mike Recher; Lucinda J Berglund; Danielle T Avery; Morton J Cowan; Andrew R Gennery; Joanne Smart; Jane Peake; Melanie Wong; Sung-Yun Pai; Sachin Baxi; Jolan E Walter; Umaimainthan Palendira; Gillian A Tangye; Michael Rice; Shannon Brothers; Waleed Al-Herz; Hans Oettgen; Hermann Eibel; Jennifer M Puck; Federica Cattaneo; John B Ziegler; Silvia Giliani; Stuart G Tangye; Luigi D Notarangelo
Journal:  Blood       Date:  2011-10-28       Impact factor: 22.113

Review 9.  Recent advances in the understanding of interleukin-2 signal transduction.

Authors:  F Gesbert; M Delespine-Carmagnat; J Bertoglio
Journal:  J Clin Immunol       Date:  1998-09       Impact factor: 8.317

10.  Tumor-shed PGE(2) impairs IL2Rgammac-signaling to inhibit CD4 T cell survival: regulation by theaflavins.

Authors:  Sreya Chattopadhyay; Sankar Bhattacharyya; Baisakhi Saha; Juni Chakraborty; Suchismita Mohanty; Dewan Md Sakib Hossain; Shuvomoy Banerjee; Kaushik Das; Gaurisankar Sa; Tanya Das
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.